Cargando…
Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
Many complex diseases such as cancer are associated with multiple pathological manifestations. Moreover, the therapeutics for their treatments often lead to serious side effects. Thus, it is needed to develop multi-indication therapeutics that can simultaneously target multiple clinical indications...
Autores principales: | Lim, Hansaim, He, Di, Qiu, Yue, Krawczuk, Patrycja, Sun, Xiaoru, Xie, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576746/ https://www.ncbi.nlm.nih.gov/pubmed/31206508 http://dx.doi.org/10.1371/journal.pcbi.1006619 |
Ejemplares similares
-
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
por: Hammam, Kahina, et al.
Publicado: (2017) -
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
por: Ciceri, Pietro, et al.
Publicado: (2014) -
A Bayesian approach to accurate and robust signature detection on LINCS L1000 data
por: Qiu, Yue, et al.
Publicado: (2020) -
Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System
por: Zhang, Chong, et al.
Publicado: (2017) -
Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions
por: Szczypka, Marianna
Publicado: (2020)